• EsoGuard Methylation Assay for Barrett’s Esophagus
  • MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Non-Invasive Prenatal Testing (NIPT) for Fetal Aneuploidy
  • Fibrinogen (Functional)
  • Inflammatory Bowel Disease Serology Panel, Serum
  • ATP-binding cassette sub-family B member 1 (ABCB1) Genotyping
  • Potassium, Serum
  • Electrophoresis, Protein, CSF
  • Fatty Acid Profile, Serum
  • Measles (Rubeola) Antibody, IgM and IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
Medical Test

Turnaround Time
Access to OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment is restricted.